Mars Symbioscience
Mars Symbioscience operates as Mars Edge, the cocoa flavanol research arm of Mars, Incorporated, conducting over 20 years of nutritional science research on cardiovascular and cognitive health with a global scientific partner network and communicating findings through the Cocoa Flavanol Science Hub.
- Company typePrivate
- Founded2005
- HeadquartersGermantown, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Mars Symbioscience does
Mars Symbioscience is an internal technology-based health and science venture area of Mars, Incorporated, founded in 2005 and headquartered in Germantown, Maryland. Operating under the brand names Mars Edge and Mars Cocoa Science, the entity has spent over 20 years conducting cocoa flavanol research aimed at establishing the role of dietary flavanols in cardiovascular and cognitive health. Its work is anchored by the Mars Edge Core Laboratory, which develops proprietary analytical methods for measuring and analyzing cocoa flavanols, and is conducted in collaboration with a global network of scientific research partners including the University of Reading.
The entity's primary public-facing product is the Cocoa Flavanol Science Hub, a web-based educational and science communications platform that aggregates research findings, peer-reviewed publications, clinical trial information (notably the COSMOS and COSMOS-Web trials), and nutrition biomarker science content. The platform serves researchers, health professionals, and health-conscious audiences rather than operating as a commercial product channel. Mars Edge does not sell products directly; instead, its research outputs and scientific evidence base are intended to support human health through nutrition and inform broader dietary guidance.
From a business model standpoint, Mars Edge functions as a research and science communications arm within the Mars, Incorporated conglomerate, funded internally rather than through standalone revenue. There is no disclosed pricing, no external customer base in the conventional sense, and no commercial distribution activity; the entity's outputs (data, publications, scientific credibility) are leveraged within Mars's broader portfolio rather than monetized as standalone products. With 51-100 employees, the unit operates at a research-segment scale rather than a commercial scale.
Mars Symbioscience firmographics
Firmographics- Name
- Mars Symbioscience
- Website
- https://marssymbioscience.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Mars Symbioscience operates as Mars Edge, the cocoa flavanol research arm of Mars, Incorporated, conducting over 20 years of nutritional science research on cardiovascular and cognitive health with a global scientific partner network and communicating findings through the Cocoa Flavanol Science Hub.
- Ownership category
- akta.pro rank
Mars Symbioscience industry classification
Industry- Product category
- Nutritional Science Research
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
- akta.pro secondary industry
- Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)
Keywords
Where Mars Symbioscience is headquartered
LocationHeadquarters
- HQ city
- Germantown
- HQ country
- United States
- HQ region
- North America
Markets served
Mars Symbioscience business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Marketing channels6 records
Mars Symbioscience product offering
Product offeringCore offering
Mars Symbioscience (doing business as Mars Edge and Mars Cocoa Science) is an internal research and science segment of Mars, Incorporated that investigates the health benefits of cocoa flavanols. Its primary offering is the Cocoa Flavanol Science Hub, an educational web platform aggregating research findings on cocoa flavanols and their effects on cardiovascular and cognitive health. The segment operates the Mars Edge Core Laboratory, applying proprietary analytical methods and biomarker research, and supports clinical trials such as COSMOS and COSMOS-Web in collaboration with global scientific partners.
Product overview
Mars Edge operates as a research-focused segment of Mars, Incorporated dedicated to supporting human health through nutrition. The primary offering is the Cocoa Flavanol Science Hub—a web-based information platform that aggregates and communicates scientific research on cocoa flavanols and their potential health benefits for cardiovascular and cognitive health. The platform does not offer commercial products but serves as an educational resource hub for research findings, clinical trial information (including COSMOS and COSMOS-Web trials), and science communication content through blogs and publications.
Differentiator
Problem solved
Functional benefit
Products and services
- Cocoa Flavanol Science Hub
- Mars Edge Core Laboratory
Quantifiable outcome
- Diet rich in flavanols supports memory and cognition
- +1 more outcomes
Companies that use Mars Symbioscience
Customer profileSegments1 record
Ideal customer profiles2 records
Mars Symbioscience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Mars Symbioscience partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Global Network of Scientific Research PartnerscoreMars Edge collaborates with a global network of leading scientific partners to investigate the potential benefits of cocoa flavanols for human health. This includes cardiovascular health research and cognitive/brain health studies conducted through clinical trials.
- University of ReadingcoreCollaboration with researchers at University of Reading on nutrition research, including investigations into limitations of food composition databases and self-reporting in nutrition research, and biomarker analysis methodologies.
Scale indicators1 record
Recent moves4 records
Expansion highlights3 records
Mars Symbioscience competitors and assessment
Company assessmentDirect peers
- Barry Callebaut: World's leading cocoa and chocolate manufacturer with its own cocoa flavanol research and Acticoa cocoa flavanol ingredient line. Directly comparable as a vertically integrated cocoa processor investing in flavanol science and premium ingredient commercialization.
- Kemin Industries: Privately held ingredient manufacturer with extensive research into bioactive compounds for human and animal nutrition. Comparable as a science-led, privately held ingredient company investing in proprietary bioactives and analytical methods.
- Glanbia Nutritionals: Global nutrition ingredient and premix manufacturer serving nutraceutical, functional food, and supplement markets. Comparable as a B2B ingredient platform with research capabilities targeting bioactive and functional nutrition.
- Metabolon: Specialized metabolomics and biomarker analytics company serving nutrition, pharma, and academic research customers. Comparable as a biomarker-focused analytical services platform analogous to Mars Edge's Core Laboratory capabilities.
Broad incumbents
- Nestlé Research: Global nutrition R&D arm of Nestlé with substantial research into bioactives, nutrition biomarkers, and health outcomes. Comparable as a large CPG-owned research segment operating in nutrition science and clinical evidence generation.
- DSM-Firmenich: Global nutrition and health ingredient company with deep R&D into vitamins, bioactives, and functional ingredients. Comparable as a science-driven ingredients platform serving nutraceutical and fortified food customers with evidence-backed offerings.
- Cargill: Major cocoa processor and food ingredient supplier with proprietary cocoa polyphenol research and ingredient offerings. Comparable as a vertically integrated cocoa/food ingredient player investing in flavanol science for premium applications.
- Hershey Company: Major chocolate and confectionery company with internal R&D into cocoa science and nutrition. Comparable as a Mars competitor with strategic interest in cocoa flavanol research for both product and ingredient positioning.
- Archer Daniels Midland (ADM): Global food and ingredient processor with cocoa origination, nutrition R&D, and functional ingredient lines. Comparable as a large agribusiness with science-based nutrition segments adjacent to Mars Edge's bioactive focus.
Emerging players
- Standard Process: Whole-food nutritional supplement company with vertically integrated growing operations and clinical research partnerships. Comparable as a smaller, privately held nutrition company investing in scientific validation of phytonutrient health claims.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Mars Symbioscience social profiles
Digital presenceMars Symbioscience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mars Symbioscience leadership team
Management profileNumber of profiles
Profiles1 record
Mars Symbioscience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mars Symbioscience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mars Symbioscience
What does Mars Symbioscience do?
Mars Symbioscience (doing business as Mars Edge and Mars Cocoa Science) is an internal research and science segment of Mars, Incorporated that investigates the health benefits of cocoa flavanols. Its primary offering is the Cocoa Flavanol Science Hub, an educational web platform aggregating research findings on cocoa flavanols and their effects on cardiovascular and cognitive health. The segment operates the Mars Edge Core Laboratory, applying proprietary analytical methods and biomarker research, and supports clinical trials such as COSMOS and COSMOS-Web in collaboration with global scientific partners.
Is Mars Symbioscience a public or private company?
Mars Symbioscience is a private company. It is classified as corporate owned and is currently operating.
When was Mars Symbioscience founded?
Mars Symbioscience was founded in 2005. It employs 51 to 100 people.
Where is Mars Symbioscience based?
Mars Symbioscience is headquartered in Germantown, United States, in the North America region.
Who are Mars Symbioscience's main competitors?
Direct peers on record are Barry Callebaut, Kemin Industries, Glanbia Nutritionals and Metabolon. Broad incumbents are Nestlé Research, DSM-Firmenich, Cargill, Hershey Company and Archer Daniels Midland (ADM). Standard Process is listed as an emerging player.
Does Mars Symbioscience have an API?
No public API is recorded for Mars Symbioscience.
What industry is Mars Symbioscience in?
Mars Symbioscience's product category is Nutritional Science Research. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP. Its NAICS code is 54171 and its SIC code is 8731.